Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.
Anne-Marieke Van DijkJörn Markus SchattenbergAdriaan G HolleboomMaarten E TushuizenPublished in: United European gastroenterology journal (2021)
Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent and potentially severe liver disease, emphasizing the need for implementation of widely supported care paths for patients at risk for advanced stages of NAFLD. In particular, the distinction of patients with a progressive and/or advanced, fibrotic NAFLD from those with simple steatosis requires improvement, as well as the awareness for NAFLD among health care professionals. Broad acceptance and implementation of interdisciplinary care paths in the near future will bring enhanced identification of those patients that benefit from surveillance, intensive lifestyle management, and empirical or investigational pharmacotherapy and enhance our epidemiological grasp of NAFLD in relation to lifestyle, genetic background, and cardiometabolic comorbidities related to NAFLD.
Keyphrases
- healthcare
- end stage renal disease
- quality improvement
- palliative care
- primary care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- multiple sclerosis
- prognostic factors
- metabolic syndrome
- public health
- peritoneal dialysis
- type diabetes
- physical activity
- randomized controlled trial
- dna methylation
- systemic sclerosis
- adipose tissue
- patient reported
- current status
- open label
- social media
- drug induced